India plans to vaccinate at least 300 million against the coronavirus.
It’s an incredibly ambitious undertaking, especially for a developing country with poor rural infrastructure and an inadequate public health system already buckling under tremendous pressure from COVID-19. But India also has its own advantages.
As a global hub for vaccine manufacturing, India’s mass production lines can churn out coronavirus vaccines — developed either domestically or by Western pharmaceutical companies — faster and cheaper than most other countries.
When it comes to the vaccination process, India already has a vast, established network under its Universal Immunization Program, which inoculates about 55 million people per year.
Prime Minister Modi also suggested the country can draw from its experience organizing the world’s largest democratic elections, adopting a whole of society approach involving states, districts, civil society, citizens and experts.